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Introduction
Activated T cells play a central role in adaptive immunity through 
cytokine secretion or the destruction of antigen-bearing cells. 
T cell activation and function require physical contact with 
antigen-presenting cells (APCs) at a specialized junction structure 
known as the immunological synapse (IS; Monks et al., 1998; 
Grakoui et al., 1999). Once formed, signal-dependent rearrange-
ments in actin cytoskeleton dynamics are absolutely necessary 
to sustain correct temporal and spatial control of the activation 
process (Huang and Burkhardt, 2007; Yu et al., 2013). Alteration 
of actin dynamics at the IS results in immune dysfunction.
Our understanding of actin cytoskeleton reorganization 
during T cell activation has advanced rapidly in the last decade 
by adding new players and gaining mechanistic insight into 
T cell biology. The actin-related protein 2/3 (Arp2/3) complex 
is a major regulator of actin dynamics in T cells, as in other 
cell types (Higgs and Pollard, 2001). Of the Arp2/3-activating 
factors, WASp (Wiskott–Aldrich syndrome protein), WIP (WASP-
interacting protein), WAVE (WASP-family verprolin-homologous 
protein), and HS1 (hematopoietic lineage cell-specific protein 1) 
are well studied in T cells, and depletion of these proteins 
individually results in poor actin polymerization and weakens 
the ability of T cells to form the IS with APCs (Huang and 
Burkhardt, 2007). Formins are a class of actin nucleators that are 
independent of Arp2/3 (Pruyne et al., 2002). Two formins, mDia1 
and FMNL-1 (formin like-1), are necessary for microtubule- 
organizing center translocation toward the IS, whereas their 
depletion has no effect on the development of normal lamel-
lipodium and IS (Gomez et al., 2007). Additionally, several 
negative regulators of F-actin have been described in T cells 
(Ichetovkin et al., 2002; Eibert et al., 2004). Cofilin is well 
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Figure 1. TAGLN2 is associated with F-actin and localizes at the d-SMAC of IS in T cells. (A) CHO-K1 cells transfected with TG2_GFP or GFP vector were 
stained with TRITC-phalloidin. The boxed areas (yellow) are represented as zoomed images in the right and bottom micrographs. (middle) The colocalization 
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characterized and functions by severing actin filaments and 
sequestering actin monomers. Depletion of cofilin results in 
the formation of increased and longer lamellipodial structures 
in T cells (Kim et al., 2014).
The structure of the actin network is also regulated through 
the actions of a variety of actin cross-linking or bundling pro-
teins. An actin cross-linking protein, -actinin, regulates IS 
formation (Gordón-Alonso et al., 2012). l-Plastin is involved 
in efficient spreading of T cells on surfaces with immobilized 
T cell receptor (TCR) ligands (Wang et al., 2010). Filamin A 
interacts with CD28 at the IS (Tavano et al., 2006). Overall, 
the studies on each of these proteins suggest that different actin 
regulators participate in different aspects of T cell activation 
and only a fully rearranged actin cytoskeleton is optimal for full 
T cell activation.
TAGLN (transgelin) family members have been identified 
as actin cross-linking/gelling proteins. The family comprises 
three isoforms, namely TAGLN1 (also known as transgelin1 or 
SM22, highly expressed in smooth muscle cells; Camoretti-
Mercado et al., 1998), TAGLN2 (also known as transgelin2 
or SM22, associated with various types of cancers; Zhang 
et al., 2002, 2010; Rho et al., 2009), and TAGLN3 (also known 
as transgelin3 or NP25, abundant in brain tissues; Mori et al., 
2004). The term “transgelin” was originally derived from the 
transformation-sensitive and rapid actin-gelling properties of 
these proteins (Shapland et al., 1993). In this study, we found 
that TAGLN2 had a modest effect on actin cross-linking or bun-
dling, whereas it substantially blocked depolymerization of and 
competed with cofilin to bind F-actin. These findings suggest 
that TAGLN2 has a unique role in actin reorganization, in ad-
dition to its previously reported function. Indeed, there is little 
information available regarding the role of actin-stabilizing pro-
teins in IS formation and subsequent T cell activation.
Our study shows that TAGLN2 is the only transgelin iso-
form present in leukocytes, and it is segregated at the distal su-
pramolecular activation cluster (SMAC; d-SMAC) within the 
IS after TCR stimulation. These results prompted us to explore 
the possibility of TAGLN2 as a potential regulator of IS forma-
tion and subsequent T cell activation. Through biochemical and 
genetic analyses, we uncovered evidence that TAGLN2 stabi-
lizes the actin cytoskeleton, leading to an increase in F-actin 
content at the IS and subsequent activation of integrin function. 
TAGLN2/ T cells are unable to sustain a conventional F-actin 
ring, thus decreasing cell adhesion and spreading after TCR 
stimulation. As a result, cytokine expression and effector func-
tion are impaired.
Results
TAGLN2 is highly expressed in 
immunogenic tissues and cells,  
and TAGLN2 knockdown reduces  
T cell activation
The calponin homology (CH) actin-binding domain is found 
in cytoskeletal and signal transduction proteins, including 
TAGLNs. A phylogenetic tree of the family of single CH domain-
containing proteins is shown in Fig. S1 A. The TAGLN family, in-
cluding TAGLN2, is evolutionarily related to Vav1 and IQGAP1, 
which are key cytoskeletal-regulatory proteins involved in 
T cell immunity.
The expressions of TAGLN1 and TAGLN3 are restricted 
to the smooth muscle (Camoretti-Mercado et al., 1998) and brain 
(Mori et al., 2004), respectively. However, the expression pat-
tern of TAGLN2 has not yet been fully characterized. Thus, we 
first tested for the presence of TAGLN2 in various human tissues 
by Northern blot analysis and observed high expression in the 
spleen (Fig. S1 B). Western blot and real-time quantitative PCR 
(qPCR) analyses of mouse tissues confirmed that TAGLN2 was 
most highly expressed in the thymus, spleen, and lymph nodes 
(Fig. S1 C). TAGLN2 expression was also detected in primary 
immune cells or immune cell lines, and we did not detect the 
presence of other TAGLNs in these cells (Fig. S1 D). The pre-
dominant expression of TAGLN2 in T cells prompted us to ex-
plore its role in cytoskeletal regulation, which is essential for 
T cell function. A dramatic reduction in IL-2 mRNA and IL-2 
protein levels was observed in human peripheral blood lympho-
cytes (PBLs) transfected with TAGLN2 siRNA after stimulation 
with Staphylococcal aureus enterotoxin E (SEE)–pulsed Raji 
B cells (Fig. S1 E), suggesting a potential role for TAGLN2 in 
T cell immunity.
TAGLN2 binds to actin and localizes at the 
d-SMAC in the IS
Just like TAGLN1 and TAGLN3 (Camoretti-Mercado et al., 
1998; Mori et al., 2004), TAGLN2 colocalized with actin stress 
fibers and also localized to the lamellipodial leading edge, 
where actin polymerization actively occurs in CHO-K1 cells 
(Fig. 1 A). Coimmunoprecipitation of actin with GFP-tagged 
TAGLN2 (TG2_GFP) before and after activation revealed that 
TAGLN2 binding to actin is stimulus independent (Fig. 1 B). 
These findings led us to analyze endogenous TAGLN2 local-
ization in primary T cells. TAGLN2 was localized to the F-actin 
ring of mouse CD3+ T cells loaded onto anti-CD3/28–coated 
of GFP and TRITC signals was estimated by the Pearson’s correlation coefficient (R). (right) R values of single cells are represented as single dots, and ≥50 
cells were examined. Horizontal bars indicate the means. *, P < 0.05 versus GFP-transfected cells. (B) J-GFP and J-TG2_GFP cells were stimulated with anti-
CD3/28. Samples were immunoprecipitated and blotted with antibodies against the indicated proteins. Data shown are representative of three independent 
experiments. IP, immunoprecipitation; IB, immunoblot; M, molecular mass. (C) Mouse CD3+ T cells on anti-CD3/28 coverslips were stained for TG2 (rabbit 
IgG, negative control) and actin. (D) J-GFP and J-TG2_GFP cells transfected with LifeAct (Life-A) on PLL-coated coverslips were imaged and fluorescence intensity 
profiles were analyzed. Images and intensity profiles are representative of >50 cells. (E) J-TG2_GFP cells were conjugated for 30 min with SEE-Raji B cells 
(ICAM-1 [IC1]). 3D and rotating views of selected zoomed images (90°) of the boxed area are shown. Also refer to Video 1. Arrows indicate accumulation of 
TG2 and ICAM1 at the synapse site. (F) J-TG2_GFP cells on anti-CD3/28 coverslips were stained for LFA-1, Arp3, myosin IIA, and F-actin. Bottom images are 
shown, and each z-stack image is shown in Fig. S2. Also refer to Videos 2–4. c, central SMAC; p, peripheral SMAC; d, d-SMAC. All images are representa-
tive of >50 cells examined from three independent experiments. DIC, differential interference contrast. Bars, 10 µm.
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Figure 2. TAGLN2 increases F-actin content and mediates long-lasting T cell adhesion and spreading. (A) J-GFP and J-TG2_GFP cells transfected with 
LifeAct (white) were loaded on anti-CD3/28 coverslips. After initial contact, time-lapse images were acquired, and single images representing 100-s time 
points are shown. Also, refer to Videos 5 and 6. Cell spreading areas were measured using FLUOVIEW program. EV, empty vector. (B) Cells were loaded 
on anti-CD3/28 coverslips, incubated for the indicated time points, and stained for F-actin, and the percentages of F-actin rings were scored and quantified. 
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coverslips (Fig. 1 C). Ectopic overexpression of TG2_GFP 
in Jurkat T cells (J-TG2_GFP) revealed TG2_GFP expression 
not only in the cytoplasm but also in the membrane compart-
ment (Fig. 1 D). Upon J-TG2_GFP cell conjugation with SEE-
loaded Raji B cells, TG2_GFP localized to the outer border of 
ICAM-1, which is a representative peripheral SMAC molecule 
present on B cells (Fig. 1 E and Video 1). To examine the lo-
calization of TAGLN2 in greater detail, J-TG2_GFP cells were 
loaded on anti-CD3/28–coated coverslips, and then, the cells 
were fixed and stained with F-actin, LFA-1, Arp3, and myosin 
IIA. TAGLN2 was most clearly seen at the outer actin ring 
(d-SMAC; Fig. 1 F, d), although it was also observed in the 
nucleus (Fig. 1 F, Fig. S2, and Video 2). TG2_GFP signals 
strongly overlapped with Arp3 at the outer ring, but not with 
LFA-1 and myosin IIA, which are representative of the middle 
ring (peripheral SMAC; Fig. 1 F, p; Fig. S2; and Videos 3 and 4; 
Yi et al., 2012). Collectively, we concluded that TAGLN2 
associates with F-actin and is a d-SMAC protein in the IS.
TAGLN2 controls the F-actin content  
in T cells
We next investigated the function of TAGLN2 in actin reorga-
nization in Jurkat T cells. A kinetic study revealed that, although 
initial cell spreading and F-actin ring formation were similar, 
TAGLN2 overexpression prolonged the duration of T cell spread-
ing and F-actin ring formation on anti-CD3/28–coated coverslips 
(Fig. 2, A and B; and Video 5 and 6). This was correlated with the 
up-regulation of total F-actin content in J-TG2_GFP cells after 
stimulation (Fig. 2 C). Accumulation of F-actin at the IS was also 
evident during T cell–APC conjugation. TG2_GFP was clearly 
overlapped with LifeAct (mCherry; Fig. 2 D, left), and the 
F-actin retention time at the contact region in J-TG2_GFP cells 
was longer than that of J-GFP cells (Fig. 2 D, right).
Conversely, targeted knockdown of TAGLN2 by siRNA 
(Fig. 2 E) resulted in diminished cell spreading and F-actin ring 
formation (Fig. 2 F). Moreover, the F-actin retention time at 
the contact region was shorter than that of scrambled siRNA-
transfected cells (Fig. 2 G). Collectively, these results demon-
strate that TAGLN2 controls total F-actin content at the IS that 
subsequently influences F-actin ring formation and spreading.
TAGLN2 controls integrin-mediated  
T cell adhesion
Previous experiments have demonstrated that the actin cyto-
skeleton can regulate integrin-mediated T cell adhesion (Burn 
et al., 1988). Inhibitors such as cytochalasin B and D (Cyt D) 
have been used to inhibit 2- and 1-mediated adhesion to 
their ligands (Rothlein and Springer, 1986). Therefore, we 
explored whether prolonged accumulation of F-actin at the IS 
may reflect integrin activation. We performed a T cell–APC 
conjugation assay and found that J-TG2_GFP cells increased 
conjugate formation over time (Fig. 3 A). Strong inhibition 
of conjugate formation in J-TG2_GFP cells treated with Cyt D 
or TS1/18 (a blocking antibody for LFA-1) demonstrated 
that TAGLN2 controls LFA-1–mediated T cell adhesion to 
APC (Fig. 3 B). TAGLN2 overexpression did not change the 
expression levels of the cell surface molecules CD3, 28, LFA-1, 
or ICAM-1 (Fig. 3 C). An ICAM-1 adhesion assay further sup-
ported TAGLN2-mediated control of integrin function (Fig. 3 D). 
Conversely, TAGLN2 deficiency reduced conjugate forma-
tion (Fig. 3 E).
TAGLN2 directly binds to F-actin and 
weakly cross-links F-actin in bundles
To understand the mechanism of TAGLN2 involvement in actin 
assembly at the IS, we first analyzed TAGLN2 and actin inter-
actions in vitro. We confirmed these interactions using a high-speed 
cosedimentation assay. TAGLN2 was recovered with F-actin in 
the pellet (Fig. 4 A), confirming the in vivo observation of associ-
ation with stress fibers or localization at the lamellipodial leading 
edge. The binding of TAGLN2 to actin monomers was saturated 
at a 1:1 ratio (Bmax = 0.9175 ± 0.102 mol/mol), with a Kd of 7.395 
µM (Fig. 4 B). TAGLN1 was reported to bundle actin filaments 
(Han et al., 2009); thus, we tested for a correlation between the 
bundling activity of TAGLN2 and the increase in the F-actin 
content of T cells. We found, by low speed centrifugation, that 
the well-known actin-bundling protein -actinin (1 µM) precipi-
tates most of the F-actin; however, TAGLN2 does not show any 
bundling activity up to a 1:2 ratio of actin to TAGLN2 (8 µM; 
Fig. 4 C). We saw bundling activity only at higher concentrations 
(16–24 µM), as assessed by low-speed centrifugation and EM 
(Fig. 4 D). In contrast to the strong, rope-like structure formed 
by -actinin, TAGLN2-actin bundles were loosened, gel-like 
structures (Fig. 4 D). The optimal ratio of actin to common actin-
bundling proteins such as fascin, fimbrin, filamin, and -actinin 
is 1:0.05 to 1:0.5 (Glenney et al., 1981; Stokes and DeRosier, 
1991; van der Flier and Sonnenberg, 2001; Gordón-Alonso et al., 
2012). However, the requirement of exceptionally higher con-
centrations of TAGLN2 needed to cross-link actin implies that 
TAGLN2 has another function other than F-actin cross-linking.
TAGLN2 stabilizes F-actin and competes 
with cofilin for binding to F-actin
The aforementioned results prompted us to consider the other 
functions of TAGLN2 in actin reorganization. We performed 
(left) Representative actin ring images were classified as ring (R), partial (P), and not cleared (N). (C) Cells were stimulated with soluble anti-CD3/28. At the 
indicated times, F-actin content was quantified using flow cytometry. The data are represented as relative fluorescence intensity compared with J-GFP cells at 
0 min. (D) Cells were preincubated for 10 min with SEE-loaded Raji B cells (ICAM-1 [IC1]). The cells were then placed on PLL for the indicated time points. 
LifeAct redistribution was quantified as described in Materials and methods. (A–D) *, P < 0.05 versus J-GFP cells. (E–G) Jurkat T cells were transfected 
with either scrambled or siRNA targeting TAGLN2 (70 nM). (E) After 48 h, TAGLN2 expression was determined by Western blot. M, molecular mass. 
(F) Cells were loaded on anti-CD3/28 coverslips for indicated time points and then stained with TRITC-phalloidin. Cell spreading area and F-actin rings 
were analyzed as in B. (G) LifeAct redistribution at the IS was determined as in D. Graphical data shown are means of three experiments ± SD, with >50 
cells. (F and G) *, P < 0.05 versus scrambled siRNA (si_SC). Bars, 10 µm.
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Figure 3. TAGLN2 controls T cell adhesion through integrin activation. (A) Representative flow cytometric profiles of conjugate formation between J-GFP or 
J-TG2_GFP cells and Raji B cells at indicated time points. The percentages of conjugates were calculated as described in Materials and methods. (B) J-GFP 
and J-TG2_GFP cells were pretreated for 30 min with or without 2 µM Cyt D, 10 µg/ml TS1/18, and 10 µg/ml TS2/4, and then, the cells were incubated 
for 30 min with SEE-Raji B cells. *, P < 0.05 versus J-GFP in each experimental condition. **, P < 0.05 versus J-TG2_GFP cells with SEE-loaded Raji 
B cells. (C) Surface expression of CD3-, CD28, LFA-1, and ICAM-1. Mean fluorescence intensity (MFI) of whole cell population is shown in each graph. 
Empty line, isotype control. (D) J-GFP and J-TG2_GFP were preincubated for 30 min with or without 10 µg/ml TS1/18 and were then applied to human 
ICAM-1-Fc coverslips for 30 min with or without anti-CD3/28 stimulation. Adherent cells were detected using a fluorescence plate reader. C, coated; 
T, treated. *, P < 0.05 versus anti-CD3/28–stimulated J-GFP cells. (E) Cells from Fig. 2 E were mixed with SEE-Raji B cells, and the percentages of conjugates 
were determined as in A. Flow cytometric plots shown are representative of three independent experiments, and results are the mean ± SD of triplicate 
experiments. *, P < 0.05 versus scrambled siRNA (si_SC) in the presence of SEE.
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an actin polymerization assay with pyrene-labeled actin and 
compared the polymerizing activity of TAGLN2 with that of 
Arp2/3 and/or the VCA (verprolin-homology, cofilin homol-
ogy, and acidic) domain of neuronal WASp (Blanchoin et al., 
2000). Although Arp2/3 and VCA successfully enhanced spon-
taneous polymerization under actin polymerization buffer 
(APB), TAGLN2 slightly reduced the kinetics of spontane-
ous actin polymerization (Fig. 5 A). We also measured the 
concentration of globular actin (G-actin) required for polym-
erization (critical concentration) in the presence or absence 
of TAGLN2 and found that addition of TAGLN2 does not 
change the critical concentration of G-actin (Fig. 5 B).
Figure 4. TAGLN2 directly binds to F-actin and weakly cross-links actin in bundles. (A) Actin was polymerized in APB and then incubated for 30 min with 
8 µM TAGLN2, 1 µM -actinin, and 1 µM BSA. After high-speed centrifugation (100,000 g), pellets were separated from supernatants and analyzed by 
SDS-PAGE. S, supernatant; P, pellet. (B) To generate standard curves, different amounts of actin (4 µM) and TAGLN2 (0.4–5.6 µM) were loaded on an SDS-
PAGE gel, and the intensities of the bands were measured by a densitometer. The actin binding affinity was measured as described in the Materials and 
methods. (C) For actin bundling assay, various doses of TAGLN2 (8–24 µM) were incubated with F-actin (4 µM). After low-speed centrifugation (10,000 g), 
pellets and supernatants of the samples were analyzed. All data shown are representative of three independent experiments. M, molecular mass. 
(D) The reactants above C were examined via EM. Images shown are representative of three independent experiments. Bar, 100 nm.
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Figure 5. TAGLN2 stabilizes F-actin and competes with cofilin for binding to F-actin. (A) Actin polymerization was performed with pyrene-labeled 4 µM 
G-actin in APB containing 10 nM Arp2/3, 400 nM VCA, 4 µM TAGLN2, or Arp2/3 + VCA. The extent of polymerization is shown in normalized fluor-
escence units. (B) Pyrene-labeled G-actin was diluted to various concentrations in the presence or absence of an equimolar concentration of TAGLN2, 
and fluorescence was measured 4 h after adding APB to initiate polymerization. Inset graph indicates fluorescence intensities of 0–16M pyrene-labeled 
G-actin mixed with same molar concentration of TAGLN2. (C) To visualize TAGLN2 and F-actin, G-actin was incubated for 1 h in APB in the presence or 
absence of TAGLN2 conjugated with Dylight 488. F-actin was stained with TRITC-phalloidin. (D) Depolymerization of actin filaments was performed in 
the presence of various concentrations of TAGLN2. 4 µM phalloidin was used as a positive control. Actin was polymerized in the presence of TAGLN2 
or phalloidin for 1 h in APB and then diluted fivefold into G buffer to initiate depolymerization. The degree of depolymerization was monitored using a 
fluorometer. (E) Actin depolymerization was performed as in D in the presence or absence of 1 µM cofilin. T/C indicates the molar ratio of TAGLN2 (T) 
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The binding of fluorescently labeled TAGLN2 along actin 
filaments (Fig. 5 C) led us to examine whether TAGLN2 may 
be involved in F-actin stabilization as a side-binding protein. 
TAGLN2 blocked spontaneous actin depolymerization in con-
centrations ranging from 1 to 8 µM, which were lower than 
those needed for bundling (Fig. 5 D). This demonstrated that 
TAGLN2 stabilizes F-actin. Moreover, TAGLN2 blocked cofilin-
mediated depolymerization, as determined by a depolymeriza-
tion assay and confocal analysis (Fig. 5 E).
The crystal structure of TAGLN1 was reported to con-
tain two cross-linked monomers of TAGLN1 (Li et al., 2008). 
Using the TAGLN1 homodimer as a template, we predicted the 
dimerization of TAGLN2 monomers (Fig. 5 F). Interestingly, 
we found a similar mode of homodimerization for TAGLN2. It 
was mediated by amino acids at the binding interface that cor-
respond to those of the TAGLN1 homodimer (Li et al., 2008). 
The structure of the homodimeric TAGLN2 model enabled 
us to predict an underlying mechanism of TAGLN2 action in 
F-actin stabilization. As shown schematically in Fig. 5 F, di-
merization of TAGLN2 monomers, through the interaction of 
one side of the first monomer (helix I and II) with the other 
side of second monomer (helix IV and V), can generate multi-
mers of TAGLN2 that stabilize an incoming actin molecule’s 
position on the growing F-actin lining. The 1:1 stoichiometry 
of TAGLN2 to actin also suggests that there is only one actin-
binding motif (ABM) on each TAGLN2 monomer (Fig. 4 B). 
These observations suggest a model in which TAGLN2 func-
tions as a “molecular staple” on polymerized actin, binding to 
actin at one end (fulcrum) and undergoing multimeric interactions 
with two arms (Fig. 5 F, right).
The ABM is required for TAGLN2-mediated 
T cell activation
Sequence alignment with TAGLN1 and TAGLN3 revealed that 
TAGLN2 contains a predicted ABM between residues 153 
and 160. Deletion of amino acids 153–160 (ABM) reduced 
TAGLN2 association with F-actin (Fig. 6, A and B). This mutant 
also lost actin-stabilizing activity (Fig. 6 C), further corroborat-
ing that the actin stabilizing activity of TAGLN2 is fully depen-
dent on its binding to F-actin. To investigate whether TAGLN2 
involvement in T cell activation is related to its binding to 
actin, we also generated J-TG2ABM_GFP cells (Fig. 6 D). 
We observed diminished accumulation of TAGLN2 at the IS, 
and the expression of IL-2 mRNA was attenuated in these 
cells compared with J-TG2_GFP cells (Fig. 6, D and E). These 
cells also failed to increase conjugate formation (Fig. 6 F). We 
questioned whether T cell activation by TAGLN2 is caused by 
its primary role in actin signaling or a secondary effect stem-
ming from increased conjugate formation. To test this, J-GFP, 
J-TG2_GFP, or J-TG2ABM_GFP cells were loaded on anti-
CD3/28–coated plates with or without ICAM-1 (±ICAM-1), 
and IL-2 production was measured. J-TG2_GFP cells on the 
anti-CD3/28+ICAM-1–coated plates produced the most IL-2. 
This suggested that TAGLN2 function is enhanced by integ-
rin LFA-1 binding to its ligand ICAM-1 (Fig. 6 G). On anti-
CD3/28–coated plates, however, production of IL-2 in J-TG2_ 
GFP cells was also increased when compared with J-GFP or 
J-TG2ABM_GFP cells (Fig. 6 G). This suggests that the 
primary role of TAGLN2 in regulation of actin is essential for 
TAGLN2-mediated T cell function.
TAGLN2 knockout leads to diminished  
F-actin content and F-actin ring formation—
resulting in lowered cell spreading—and 
shows attenuated cofilin activity in vivo
To connect the in vitro and in vivo data, we generated mice de-
ficient in TAGLN2 (Fig. S3, A and B). The sizes of primary and 
secondary lymphoid organs were not changed, and the weights of 
age-matched littermates also did not differ significantly among 
wild-type (WT; +/+), heterozygous (+/), and TAGLN2-null 
(/) mice (Fig. S3, C and D). The absence of TAGLN2 ex-
pression was confirmed using Western blotting (Fig. S3 E). The 
TAGLN2/ mice showed normal T cell development, in terms 
of the number and percentage of CD4+ and CD8+ single-positive 
cells in the thymus, lymph nodes, and spleen (Fig. S3 F), as well 
as normal B cell and dendritic cell populations in the spleen 
(Fig. S3 G). CD3+ T cells showed normal surface expression 
of CD3- and CD28 (Fig. S3 H). Response to lipopolysaccha-
ride was not significantly altered in either dendritic cells (DCs; 
Fig. S3 I) or B cells (Fig. S3 J) taken from TAGLN2/ mice.
We also generated transgenic mice by using an Lck 
(lymphocyte-specific protein tyrosine kinase) promoter-based 
vector containing GFP or TG2_GFP, and we verified the GFP 
signals within well-defined T cell regions in lymphoid organs such 
as the thymus, spleen, and lymph nodes (Fig. S4 A). The expres-
sion levels of GFP and TG2_GFP were confirmed (Fig. S4 B). 
The mice exhibited normal T cell development as determined 
by the ratio of CD4+/CD8+ cells (Fig. S4 C).
We compared cell spreading and F-actin ring formation 
in CD3+ T cells purified from TAGLN2+/+ and TAGLN2/ mice 
before and after stimulation on anti-CD3/28–coated coverslips. 
A kinetic study revealed that the TAGLN2 deficiency inhib-
ited cell spreading as well as diminished F-actin ring forma-
tion (Fig. 7 A). These cells showed a reduction in total F-actin 
content after T cell stimulation (Fig. 7 B). TAGLN2/ CD3+  
T cells showed a significant reduction of conjugate formation with 
SEE-loaded CD19+ B cells purified from WT mice (Fig. 7 C). 
The ability to adhere to ICAM-1 was also diminished in these 
cells, suggesting weakened LFA-1 function (Fig. 7 D).
We next examined the relationship between TAGLN2 
and cofilin in vivo. Because active cofilin functions to rap-
idly disassemble F-actin, we tested the ability of TAGLN2 to 
and cofilin (C) in the reaction. (top) Total change in pyrene intensities (F) were calculated as described in Materials and methods. Results represent means ± 
SD of triplicate experiments. For confocal image analysis, pyrene-labeled G-actin was replaced with 488–G-actin. All data shown are representative of at 
least three independent experiments. (F) Prediction of the ribbon structure of a TAGLN2 homodimer using Chimera software. (left) Black arrows indicate the 
actin-binding motif (ABM). (right) TAGLN2 dimer and multimers are shown schematically. The TAGLN2 dimer is represented by triangular monomers with 
helices I and II, helices IV and V, and ABM at the three vertices represented by arcs. Bars, 5 m.
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Figure 6. Mutation at actin binding site loses functions of F-actin stabilization and T cell activation. (A) Schematic diagram of wild type (WT)–TG2 and 
TG2ABM. CH, calponin homology; ABM, actin-binding motif; CR, calponin repeat. CHO-KI cells transfected with WT-TG2_GFP or TG2ABM_GFP were 
stained for F-actin (TRITC-phalloidin), and colocalization between GFP and TRITC was calculated with the FLUOVIEW and represented as a percentage 
(bottom). Images are representative of >50 cells examined. Results represent means ± SD of triplicate experiments. *, P < 0.05 compared with cells expressing 
WT-TG2. EV, empty vector. (B and C) F-actin binding (B) and actin depolymerization (C) assays were performed as described in Fig. 4 A and Fig. 5 D. Data 
shown are representative of three independent experiments. M, molecular mass; S, supernatant; P, pellet. (D) J-GFP, J-TG2_GFP, and J-TG2ABM_GFP 
were incubated with SEE-loaded Raji B cells for 30 min. (left) The arrows indicate the accumulation of GFP signals at the IS. The ratio of contact/opposite 
fluorescence was calculated. The ratio of contact/opposite fluorescence in the white boxed area was calculated. Each dot represents 50 cells examined. 
Horizontal bars indicate the mean of fluorescence intensities. Data shown are representative of three independent experiments. T, J-GFP, J-TG2_GFP, and 
J-TG2ABM_GFP cells; B, Raji B cells. (E) IL2 mRNA levels were measured using real-time quantitative RT-PCR. (F) Conjugate formations were determined as 
described in Fig. 3. (G) IL-2 secretions in each condition were assessed by ELISA. Results are the means ± SD of triplicate experiments. *, P < 0.05 versus 
J-GFP; **, P < 0.05 versus J-TG2_GFP. T, TAGLN2; C, cofilin. Bars, 10 µm.
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overcome cofilin-mediated actin depolymerization in CHO-K1 
cells. We generated an active form of cofilin by substitution of 
Ser-3 to Ala-3 (cofilin/S3A; Moriyama et al., 1996). Overexpres-
sion of TAGLN2 markedly protected F-actin within stress fibers 
from cofilin-mediated destruction, whereas the actin-binding 
mutant (ABM) had little effect (Fig. 8 A). In Jurkat T cells, co-
filin/S3A led to impaired spreading (area) on anti-CD3/28–coated 
plates, presumably as a result of the excessive depolymeriza-
tion of F-actin (Fig. 8 B and Video 7). However, cotransfection 
with WT-TG2, but not TG2ABM, blocked the cofilin effect 
(Fig. 8 B), thereby corroborating that TAGLN2 antagonizes cofilin 
activity in vivo as it does in vitro. Cofilin almost similarly colocal-
ized with TAGLN2 (Fig. 8 B and Video 8). Surprisingly, however, 
careful examination revealed that cofilin mainly localized at two 
distinguishable regions in the IS—the central SMAC (correspond-
ing to the “F-actin hole”) and upper region of d-SMAC—where 
TAGLN2 is rather excluded (Fig. 8 C), suggesting specific loca-
tions of two proteins for opposite functions in the IS.
Figure 7. A TAGLN2 knockout leads to diminished F-actin content and F-actin ring formation, resulting in lowered cell spreading and LFA-1–mediated 
conjugation formation. (A) T cells from TAGLN2+/+ and TAGLN2/ mice were loaded on anti-CD3/28–coated coverslips for the indicated time points. 
Images shown are representative of three independent experiments. Cell spreading area and the percentages of actin rings were measured, as shown in 
Fig. 2 (A and B). R, ring; P, partial. Bar, 10 m. (B) Relative F-actin content was measured as in Fig. 2 C. KO, knockout. (C) Mouse CD3+ T cells were 
mixed with SEB-loaded B cells, and conjugate formation for the indicated time points was determined as in Fig. 3 A. (D) BCECF-labeled mouse CD3+ T cells 
were preincubated for 30 min with or without 2 µM Cyt D, and then, adhesion to mICAM-1Fc in response to anti-CD3/28 was determined by measuring 
fluorescence intensity. All graphical results represent means ± SD of triplicate experiments. *, P < 0.05. T, TAGLN2; C, cofilin.
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Figure 8. TAGLN2 antagonizes cofilin in vivo, and TAGLN2/ T cells show substantial retardation of cofilin activity upon TCR stimulation. (A) CHO-K1 
cells were transfected with the indicated constructs and then stained with Alexa Fluor 647–phalloidin. The integrated fluorescence (Fl) of F-actin in each 
transfected cell was estimated by FLUOVIEW. (B) Jurkat T cells were cotransfected with the indicated constructs. Cells were loaded on anti-CD3/28–coated 
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approximately a twofold increase in IL-2 or IFN- expression 
in response to the indicated stimuli (Fig. S4, D–F).
We next assessed the ability of CD8+ T cells to kill target 
cells. TAGLN2/ CD8+ T cells exhibited a profound decrease 
in target cell lysis (Fig. 9 D). Flow cytometric analysis of 
TAGLN2/ CD8+ T cells showed reduced expression of lytic 
granules (granzyme B and perforin) after stimulation (Fig. 9 E), 
along with the consistent reduction in the secretion of mature 
granzyme B (Fig. 9 F). On the other hand, CD8+ T cells also 
showed a reduced conjugation to target cells (Fig. 9 G). These 
results suggest that decreased cytotoxicity of TAGLN2/ CD8+ 
T cells is resulted from both reduced expression of lytic gran-
ules and weakened adhesion to target cells.
To further confirm that defects in the actin-binding abil-
ity of TAGLN2 also affect T cell spreading and activation 
in vivo, we performed retroviral transduction/reconstitution 
experiments in TAGLN2/ T cells. In contrast to WT cells, 
TG2ABM cells did not properly form F-actin rings when re-
constituted cells were loaded on anti-CD3/28–coated cover-
slips (Fig. 9 H). Moreover, the mutant failed to mediate normal 
T cell activation when the reconstituted cells were incubated 
with SEB-loaded CD19+ B cells (Fig. 9 I). To further deter-
mine whether the signaling defects in TAGLN2 knockouts are 
a direct result of TAGLN2 function on F-actin polymerization, 
or a secondary defect in integrin-mediated cell adhesion, the 
reconstituted cells were loaded on anti-CD3/28–coated plates 
with or without ICAM-1 (±ICAM-1), and intracellular signaling 
was examined. In contrast to the TAGLN2+/+ or WT-transduced 
TAGLN2/ T cells, ABM-transduced T cells were not op-
timally phosphorylated in either condition (±ICAM-1; Fig. 9 J). 
These results strongly suggested that direct modulation of actin 
reorganization is most critical for TAGLN2 function and that 
integrin-mediated adhesion is important.
Discussion
Once the IS is established, the surface of the distal region is 
enriched in molecules with large extracellular domains, such 
as CD43 and CD45 (Delon et al., 2001; Freiberg et al., 2002), 
whereas a stable centripetal retrograde actin flow drives and 
regulates T cell activation in the cytoplasmic region (Babich 
et al., 2012). To meet the needs of spatial and temporal regula-
tion in the IS, actin polymerization and depolymerization are 
tightly regulated by many accessory proteins like Arp2/3, WASp, 
WAVE, cofilin, and HS12 (Huang and Burkhardt, 2007). We 
have found that another actin binding protein, TAGLN2, colocal-
izes with F-actin in d-SMAC and controls F-actin levels at the 
IS by stabilizing F-actin and in part antagonizing cofilin-mediated 
Although most studies have associated cofilin activation 
with F-actin depolymerization, this relationship does not al-
ways hold. Indeed, cofilin activity favors F-actin polymeriza-
tion via its actin-severing activity in vivo and is therefore known 
to positively regulate T cell activation (Samstag et al., 2003). 
If this is the case, there must be signaling cross talk or a co-
operative function, but not opposition, between TAGLN2 and 
cofilin in vivo. Interestingly, we found that the dephosphoryla-
tion (activation) of cofilin was not obvious in TAGLN2/ CD3+ 
T cells after anti-CD3/28 stimulation, whereas the total amount 
of cofilin was similar in both types of T cells (Fig. 8 D). The 
opposite of this effect was also seen in transgenic TG2_GFP 
CD3+ T cells (Fig. 8 D). In addition, we observed reduced phos-
phorylation of phosphoinositide 3-kinase (PI3K) and extra-
cellular signal–regulated kinase (ERK), an upstream Ras-signaling 
cascade of cofilin dephosphorylation (Wabnitz et al., 2006), in 
TAGLN2/ CD3+ T cells (Fig. 8 E).
TCR triggering leads to proximal and distal intracellular 
signaling events that are related to actin dynamics. As shown 
in Fig. 8 F, none of the proximal molecules showed impaired 
phosphorylation after TCR stimulation in TAGLN2/ CD3+  
T cells. This could be explained by the fact that none of these 
signaling molecules require actin for recruitment to the IS (Larghi 
et al., 2013). On the other hand, the phosphorylation of PLC- 
was attenuated in TAGLN2/ CD3+ T cells (Fig. 8 F). This 
impairment attenuated distal signaling by reducing PKC- and 
ERK activation (Fig. 8 F). PLC- phosphorylation depends not 
only on recruitment to the IS but also on correct spatial orga-
nization, driven by F-actin polymerization and retrograde flow 
(Babich et al., 2012). These results suggest that TAGLN2 plays 
a role in the spatial organization of IS, which is essential to 
maintain signaling activation.
TAGLN2 positively regulates  
T cell activation
Finally, we examined the physiological significance of TAGLN2 
in T cell immunity. CD3+ T cells from TAGLN2/ mice 
showed decreased secretion of IL-2 after incubation with the 
S. aureus enterotoxin B (SEB)–loaded CD19+ B cells or stimu-
lation with anti-CD3/28 antibodies (Fig. 9 A). To evaluate more 
antigen-specific effector functions, we generated OTII TCR+ 
and OTI TCR+ mice with or without TAGLN2 gene. Purified 
CD4+ or CD8+ T cells from OTII TCR+/TAGLN2/ and OTI 
TCR+/TAGLN2/ mice, respectively, showed a significant re-
duction of IFN- and IL-2 protein levels (Fig. 9 B) along with 
the decreased proliferation in response to the specific ovalbumin 
(OVA) peptides (Fig. 9 C). Conversely, CD3+, CD4+, and 
CD8+ T cells from transgenic mice with TG2_GFP exhibited 
coverslips for 5 min, fixed, and stained with Alexa Fluor 647–phalloidin. Images are representative of >50 cells examined. The areas and fluorescence 
intensity of F-actin were analyzed by FLUOVIEW. Data are means ± SD of triplicate experiments. (A and B) *, P < 0.05 versus empty vector (EV). **, P < 
0.05 versus cofilin alone. (C) Live images of TG2_GFP and cofilin/S3A_RFP were acquired from cells in B. The colocalization (yellow and blue circles) 
was estimated as described in Fig. 1 A. The yellow arrows indicate the F-actin hole. The boxed area (yellow) is represented as 4× zoomed images in the 
right and quantitated by fluorescence intensity. Data are representative of >50 cells examined. (D–F) Indicated CD3+ T cells were stimulated with an anti-
CD3/28 for the indicated time points. (D) The phosphorylated and total forms of cofilin were assessed by Western blotting. The phosphorylated and total 
forms of PI3K and ERK (E), Lck, Zap70, PLC-, and PKC- (F) were also detected by Western blotting. The data are representative of three independent 
experiments. DIC, differential interference contrast; M, molecular mass. Bars, 10 µm.
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Figure 9. TAGLN2 is necessary for effector T cell function. (A) CD3+ T cells from TAGLN2+/+ and TAGLN2/ mice were stimulated with anti-CD3/28 or 
incubated with SEB-pulsed CD19+ B cells for 24 h, and the levels of IL-2 production were measured using ELISA. CON, control. (B) OTII TCR+ CD4+ or OTI 
TCR+ CD8+ T cells from TAGLN2+/+ and TAGLN2/ mice were stimulated with or without OVA-loaded DCs for 24 h. IFN- and IL-2 in the supernatant were 
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but rather cooperate to regulate a stable centripetal retrograde 
actin flow during IS formation. From this point of view, it is 
interesting that TAGLN2 deficiency results in attenuated cofilin 
activity in T cells. There are at least two explanations for the 
down-regulation of cofilin activity in TAGLN2/ T cells. First, 
TAGLN2/ T cells may attenuate cofilin activity to restore 
the F-actin content, which was reduced by loss of TAGLN2. 
Therefore, active cofilin may further exacerbate the deficiency 
of TAGLN2 in T cells. Alternatively, TAGLN2/ may attenu-
ate actin-linked signaling pathways including PLC, PI3K, and 
ERK, presumably caused by the immature actin structure at the 
IS. Indeed, both PI3K and ERK overlap with the Ras-signaling 
cascade that regulates dephosphorylation of cofilin in human un-
transformed T cells (Wabnitz et al., 2006). Thus, down-regulation 
of cofilin activity might be a natural result of attenuated actin-
linked signaling in TAGLN2/ T cells.
Another question is why cells do not simply make less co-
filin, instead of expressing TAGLN2 to keep actin stable. In this 
regard, if cellular concentrations of TALN2 are substoichio-
metric to active cofilin, its role as a cofilin antagonist is unclear. 
However, we found that the cellular concentration of TAGLN2 
is much higher than cofilin in T cells, as determined by quan-
titative Western blotting (Fig. S5). Moreover, our preliminary 
results demonstrated that substitution of putative phosphoryla-
tion sites in TAGLN2 influences its actin-stabilizing function, 
while having little effect on F-actin binding (unpublished data). 
Although more careful experiments are needed to understand 
how TAGLN2 phosphorylation controls F-actin stabilization, 
these results strongly suggest that T cells require TAGLN2 to sta-
bilize F-actin levels, thereby controlling T cell function under 
diverse physiological conditions.
Although intracellular signals such as Zap70 and Erk1/2 
are necessary to activate LFA-1, the actin cytoskeleton also 
plays a role in LFA-1–mediated adhesion (Lub et al., 1997; 
Sampath et al., 1998). In the present study, increase in T cell 
conjugation with APC or adhesion to ICAM-1, with WT trans-
fection but not with ABM, suggests that actin regulation by 
TAGLN2 is linked to LFA-1 affinity or avidity changes. How-
ever, this fact raises an important question about whether the bi-
ological effectiveness of TAGLN2 is primarily caused by actin 
regulation, a secondary effect stemming from LFA-1 adhesion, 
or both. The current results show that primary actin signaling is 
critical, but a secondary function to enhance LFA-1–mediated 
T cell adhesiveness may also be important, particularly in cases 
disassembly. This function is also connected to the up-regulation 
of LFA-1 activity in T cells. Furthermore, transgenic or knockout 
T cells showed up-regulated or impaired activation, demonstrat-
ing that TAGLN2 is an important actin regulator in T cells.
The similarities between TAGLN2 and its other two fam-
ily members, TAGLN1 and TAGLN3, indicate actin-bundling 
or -gelling functions (Shapland et al., 1993; Han et al., 2009); 
however, we detected actin bundling effects only at exception-
ally high concentrations of TAGLN2 (four to eightfold greater 
than actin). Because most actin-bundling proteins can optimally 
cross-link actin into bundles at concentrations 2–20-fold lower 
than actin (Glenney et al., 1981; Stokes and DeRosier, 1991; 
van der Flier and Sonnenberg, 2001; Gordón-Alonso et al., 
2012), it is unlikely that TAGLN2-actin bundling is related to 
its biological function under physiological conditions. Instead, 
we found that TAGLN2 could stabilize and protect F-actin from 
cofilin-mediated depolymerization, which was also confirmed 
by confocal microscopy. The inability of the actin-binding mu-
tant to protect F-actin and to enhance T cell activation suggests 
that TAGLN2 function is dependent on binding to actin. The 
mechanism of TAGLN2 stabilization and, further, protection 
of F-actin from cofilin attack is currently undetermined. We 
can rule out a role in capping of barbed ends, as the proteins in 
this category significantly affect spontaneous polymerization. 
Instead, we hypothesize that TAGLN2 binds along the side 
of actin filaments and may stabilize filaments by altering their 
structure, as previously reported (Stokes and DeRosier, 1987). 
Thus, we suggest a “molecular staple” model for TAGLN2-me-
diated F-actin stabilization, as described in Fig. 5 F. This fea-
ture may be especially beneficial for blocking cofilin activity, 
as cofilin severs actin filaments by increasing their bending and 
twisting elasticity (McCullough et al., 2011).
Cofilin is a small, ubiquitously expressed protein that is 
essential for cell survival and for T cell activation. Although 
cofilin is an actin-severing protein, its activity can favor F-actin 
polymerization, because cofilin activity generates actin mono-
mers and new barbed ends where active Arp2/3 complexes 
can associate and promote F-actin elongation (Huang and 
Burkhardt, 2007). In this regard, it is very interesting to find that 
cofilin mainly localizes at upper region of d-SMAC—TAGLN2 
is rather excluded at this region and enriched at the bottom re-
gion—during IS formation. As these two molecules function 
oppositely in vivo as well as in vitro, these results suggest that 
TAGLN2 and cofilin may not compete with each other in vivo 
measured using ELISA. (A and B) All data represent the means ± SD of three independent experiments. *, P < 0.05 versus WT. (C) After 72 h, cell division 
was monitored by flow cytometry of CFSE-labeled T cells. Data are one representative of three individual experiments, each with three mice per group. 
(D) After 4-h coincubation of OTI TCR+ CD8+ T cells with OVA-loaded or -unloaded EL4 cells, ex vivo cytotoxicity was tested at various ratios of effector/
target cells. The data represent the mean ± SD of three independent experiments. *, P < 0.05 versus WT. (E) OTI TCR+ CD8+ T cells were stimulated with 
200 nM PMA and 1 µM ionomycin, and cellular expression of granzyme B and perforin was determined by flow cytometry. The boxed areas indicate the 
CD8+ granzyme Bhigh or CD8+ perforinhigh population. Data are one representative of three individual experiments, each with three mice per group. MFI, 
mean fluorescence intensity. (F) Under the condition as described in D, secretion levels of granzyme B were measured using ELISA. (G) Conjugate formation 
was also quantitated after 30-min incubation of OTI TCR+ CD8+ T cells with OVA-loaded EL4 cells. (H) TAGLN2+/+ or TAGLN2/ CD3+ T cells were retro-
virally transduced with empty vector (EV), WT-TG2, or TG2ABM. Reconstitution was confirmed by Western blotting. Cells were loaded on anti-CD3/28 
coverslips for 5 min and stained for TG2 and F-actin. Cell spreading was determined. Images are representative of >50 cells examined. Bar, 5 µm. (I) Cells 
were also incubated with SEB-pulsed CD19+ B cells for 24 h, and IL-2 levels were measured using ELISA. NT, not treated. (F–I) Data are means ± SD of 
triplicate experiments. *, P < 0.05 versus empty vector–expressing T cells. +, P < 0.05 versus WT-expressing T cells. (J) Cells were loaded on anti-CD3/28 
coverslips, with or without ICAM-1(±ICAM-1). After 10 min, the cells were lysed, and Western blotting was performed, as shown in Fig. 8 (D and E). The 
data are representative of two independent experiments. KO, knockout; M, molecular mass.
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of cytotoxic T lymphocyte–mediated cytotoxicity against target 
cells. However, further studies are necessary to elucidate how 
TAGLN2/actin signaling is connected to LFA-1 activation.
In summary, our results indicate that TAGLN2 is a d-SMAC 
molecule in the IS and plays a key role in mature synapse for-
mation by binding and stabilizing actin. We also provide ini-
tial evidence linking TAGLN2 with T cell immunity through 
its role in cytokine production and cytotoxic effector function. 
TAGLN2 is the only transgelin family member expressed in 
immune cells. Moreover, the ability of TAGLN2 to influence 
activation of T cell immunity may be involved in a variety of 
immune responses and diseases including cancer, infectious dis-
eases, septic shock, autoimmune diseases, and immediate and 
delayed type hypersensitivity reactions.
Materials and methods
Reagents and antibodies
Rabbit polyclonal anti-TAGLN2 and anti-GFP antibodies were raised in 
rabbits using purified full-length TAGLN2 and GFP proteins (AbFrontier). 
Rabbit polyclonal anti-TAGLN antibody, mouse polyclonal anti-GFP, and 
anti–PLC- antibodies, and goat polyclonal anti–-actin antibody were pur-
chased from Santa Cruz Biotechnology, Inc. Rabbit polyclonal antibodies 
against p-PI3K, p-Zap70, Zap70, Lck, ERK, p-ERK, p-PLC-, p-PKC-, PKC-, 
and p-cofilin; horseradish peroxidase–conjugated anti–mouse IgG; and 
anti–rabbit IgG antibodies were obtained from Cell Signaling Technology. 
Mouse monoclonal antibodies against TAGLN3, myosin IIA, Arp3, and co-
filin were purchased from Abcam. Anti–human and –mouse CD28 antibod-
ies were acquired from R&D Systems. FITC-conjugated anti–mouse CD4, 
and peridinin chlorophyll protein complex (PerCP) Cy5.5-conjugated CD8-
 antibodies were purchased from eBioscience. Anti–goat IgG, anti–hamster 
IgG, TRITC-conjugated anti–mouse IgG, TRITC-phalloidin, poly-l-lysine 
(PLL), and OVA were purchased from Sigma-Aldrich. OKT3 (human anti-
CD3; CRL-8001) and 145-2C11 (mouse anti-CD3; CRL-1975) hybridoma 
cell lines were purchased from the ATCC. TS1/18 (anti–human LFA-1; 
HB-203) and R6.5 (anti–human ICAM1) hybridoma cell lines were a gift 
from T.A. Springer (Harvard Medical School, Boston, MA). Lipofectamine 
2000 reagent, Alexa Fluor 647 phalloidin, and carboxyfluorescein succin-
imidyl ester (CFSE) were obtained from Life Technologies. siRNA-targeting 
TAGLN2 (M-011468-02; 5-GCAAGAACGUGAUCGGGUU-3; 5-UAU-
GUGAGCUCAUUAAUGC-3; 5-CAACUGGUUCCCUAAGAAA-3; 
5-UGCAAGCAGCUGAGCGCUA-3) and a scrambled siRNA (D-001810-01; 
5-UAAGGCUAUGAAGAGAUAC-3) were obtained as a pool of four 
siRNA duplexes from Thermo Fisher Scientific. SEE and SEB were obtained 
from Toxin Technology. OVA 257–264 and OVA 323–339 peptides were 
purchased from InvivoGen.
Cells
Jurkat T cells (TIB-152; ATCC), A7r5 (CRL-1444; ATCC), HEK293T (CRL-
1573; ATCC), CHO-K1 (10061; Korean Cell Line Bank) cells, EL4 (TIB-39; 
ATCC), and Raji B cells were maintained in RPMI 1640 medium or DMEM 
medium (Gibco/Invitrogen) supplemented with 10% (vol/vol) FBS (Gibco/
Invitrogen). After written informed consent, human primary PBLs were iso-
lated from healthy donors using dextran sedimentation and centrifugation 
through a discontinuous Ficoll gradient (GE Healthcare). Mouse CD3+  
T cells were purified from the mouse spleen and lymph nodes on a T cell 
enrichment column (R&D Systems). Mouse splenocytes were dispersed and 
purified to CD4+, CD8+, and CD19+ populations by MACS cell separation 
(Miltenyi Biotec). The purity of each population was confirmed to be >95% 
by flow cytometry.
Mice
For generation of TAGLN2 knockout mice, murine genomic DNA for 
TAGLN2 was obtained from 129/SvJ mouse J1 embryonic stem (ES) cells 
by PCR. A targeting vector was constructed to delete nucleotides 14,691–
15,479 containing exon 2 of TAGLN2 using a long arm fragment and 
two short arm fragments ligated into the pOSDupDel.Neo vector. The tar-
geting vector was then electroporated into 129/SvJ ES cells after linear-
ization using NotI. Positive recombinant ES cells were identified using 
PCR and then microinjected into C57BL/6 blastocysts. The resulting chimeric 
mice were then mated with C57BL/6 mice. Germline transmission was 
confirmed using Southern blot analysis (Macrogen). Interbreeding of the 
heterozygous mice was performed to generate homozygous TAGLN2- 
deficient mice.
Transgenic mice expressing GFP or TG2_GFP on T cells were estab-
lished. The cDNA fragments corresponding to GFP or human TAGLN2_GFP 
were subcloned into a transgenic expression vector containing the proximal 
murine p56Lck promoter and the introns and exons of the human growth hor-
mone gene (Chaffin et al., 1990). The resulting plasmids were used to gener-
ate transgenic mouse lines according to standard protocols (Macrogen).
Ova-specific TCR transgenic line I (OTI) mice contain transgenic in-
serts for mouse Tcra-V2 and Tcrb-V5 genes for recognition of OVA 257–
264 in the context of H2-Kb, and ova-specific TCR transgenic line II (OTII) 
mice contain transgenic inserts for mouse -chain and -chain TCR subunits 
expressed by a CD4+ T cell hybridoma designated clone 1.1, which is 
specific for OVA 323–339 in the context of H2-Ab1 (I-Ab; The Jackson 
Laboratory). TAGLN2/, GFP, and TG2_GFP mice were then crossed with 
OTI mice to generate OTI TCR+/TAGLN2/, OTI TCR+/GFP, and OTI 
TCR+/TG2_GFP mice for five generations. OTII TCR+/TAGLN2/, OTII 
TCR+/GFP, and OTII TCR+/TG2_GFP mice were also generated by back-
crossing in the same way as OTI mice. All mouse lines were confirmed by 
PCR using genomic DNA. All mice were housed in specific pathogen-free 
conditions, and all experiments were approved by the Animal Care and 
Use Committee of the School of Life Sciences, Gwangju Institute of Science 
and Technology.
cDNA constructs
To generate TAGLN2 constructs, a human TAGLN2 clone coding for the 
full-length open reading frame was purchased from ImaGene. The human 
WT TAGLN2 coding sequence region was ligated to pCDNA3 vector (cy-
tomegalovirus [CMV] promoter; Invitrogen), pEGFP-N1 vector (CMV pro-
moter; Takara Bio Inc.), and pHJ-1 as a lentiviral vector (CMV promoter). 
TAGLN2ABM (154–161) was generated by overlapping PCR. The 408– 
and 81–base pair products from first-round PCR were used together as an 
overlapping template to generate TAGLN2ABM.
To produce His-tagged TAGLN2 and TAGLN2ABM recombinant 
proteins, the pET-28a vector was used as an expression vector, which 
has a T7 promoter and provides six His residues at the N terminus of 
the expressed protein. The coding sequences of TAGLN2 and mutant 
TAGLN2 were amplified by PCR, and the products were incorporated into 
pET-28a. For retroviral transduction to mouse primary T cells, TAGLN2 and 
TAGLN2ABM genes were subcloned into the pRV-GFP vector, which is a 
retroviral plasmid that directs the expression of GFP.
Cofilin cDNA was amplified from cofilin mRNA, and then, the con-
stitutively active mutant cofilin (cofilin/S3A) was constructed by substituting 
Ser-3 with alanine. The PCR product was inserted into pERFP_N1 (CMV 
promoter; Takara Bio Inc.).
Cell transfection and lentiviral infection
Transient transfection to human PBLs and Jurkat T cells was mostly per-
formed by Amaxa technology using the human T cell nucleofector and 
nucleofector kitV (Lonza). Transfection to CHO-K1 cells was performed 
using Lipofectamine 2000 (Life Technologies). To establish stable cell lines, 
cDNAs in pHJ-1 vector were cotransfected with lentiviral packaging vec-
tors into 293T cells. After 48 h, the supernatants were collected and spin 
infected into Jurkat T cells by centrifugation at 800 g for 30 min in the 
presence of 8 µg/ml polybrene.
T cell stimulation
Mouse CD3+ T cells, PBLs, and Jurkat T cells were stimulated with 
10 µg/ml anti-CD3 (OKT3 for human; 145-2C11 for mouse)/2 µg/ml 
CD28 and secondary goat or hamster IgG antibody (5 µg/ml) for the 
times indicated in the text. In some cases, T cells were stimulated by 
25 µg/ml anti-CD3/2 µg/ml CD28 with or without ICAM-1–coated cov-
erslips. For superantigen stimulation, T cells were incubated with 1 µg/ml 
SEE-pulsed Raji B cells or 1 µg/ml SEB-pulsed mouse CD19+ B cells. For 
OVA stimulation, CD4+ and CD8+ T cells isolated from spleens of OTII 
TCR+/TAGLN2+/+,/ and OTI TCR+/TAGLN2+/+,/ mice, respectively, 
were cultured with T cell–depleted splenocytes pulsed with 10 µg/ml of 
OVA 323–339 (OTII) and OVA 257–264 (OTI) for 24 h.
Western blot and Northern blot analysis
Cells or homogenized tissues from a C57BL/6 mouse were lysed in ice-
cold lysis buffer (50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 1% 
Triton X-100, one tablet of Complete protease inhibitors, and phosphatase 
inhibitors) for 1 h on ice. Cell lysates were centrifuged at 16,000 g for 
159TAGln2 stabilizes actin filaments • na et al.
The cells were fixed, washed with PBS, and permeabilized with 0.1% Triton 
X-100 in PBS for 10 min. The cells were then blocked with 1% BSA in PBS 
for 1 h, rinsed with PBS, and incubated with primary antibodies in blocking 
buffer overnight at 4°C. Secondary antibodies were added after washing, 
incubated for 1 h at room temperature in the dark, rinsed with PBS, and in-
cubated for 30 min at room temperature with TRITC-phalloidin or Alexa 
Fluor 647–phalloidin in PBS to stain actin. The cells were then washed and 
mounted with Fluorescent Mounting Medium (Dako). Images were ob-
tained using a 100×, NA 1.40 oil immersion objective of a laser-scanning 
confocal microscope (FV1000). For the 3D localization assay, z stacks 
were generated from optical sections taken at 0.2-µm intervals, and 
FLUOVIEW program and Volocity software (PerkinElmer) were used for 3D 
image reconstruction.
Image analysis
The fluorescence intensity profiles were measured by the FLUOVIEW 
program. To determine the percentage of F-actin ring formation on anti-
CD3/28–coated coverslips, actin rings were assessed as ring (R), partial 
(P), and not cleared (N) and quantified using the following equation: per-
centage of actin ring formation = (R + P)/(R + P + N) × 100. Actin accumu-
lation at the contact sites in the T cells during IS formation was calculated 
as the ratio between the mean fluorescence intensity of LifeAct in the half 
portion of contact side (a) and distal side (b) in the T cells. At least 50–100 
cells or conjugates were counted in each of three independent experi-
ments. All data were plotted using KaleidaGraph (Synergy Software).
Cell adhesion assay
96-well flat-bottom plates (Thermo Fisher Scientific) were coated with 
human or mouse rICAM-1-Fc (R&D Systems) or 1% BSA (Sigma-Aldrich) 
as a negative control. Cells were labeled with 0.5 µM BCECF (2,7-
bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein; Invitrogen), washed, 
resuspended in culture media, and then pretreated with or without 
10 µg/ml TS1/18 or 2 µM Cyt D. For TCR stimulation, cells were incu-
bated for 30 min at 37°C in media supplemented with anti-CD3/CD28 
antibodies. T cells were added in triplicate to coated plates (105 cells/
well) containing secondary anti-IgG as a cross-linker and incubated for 
30 min at 37°C. Input was determined by using a fluorescence plate 
reader (Molecular Devices). Unbound cells were removed by washing 
three times with warm PBS, and cell adhesion was calculated by divid-
ing the fluorescence emission of bound cells by the total emission of all 
cells seeded per well.
Conjugation assay
Jurkat T cells and Raji B cells were stained with CellTracker Orange 
CMTMR (5-(and-6)-((4-chloromethyl)benzoyl) amino) and Green CMFDA 
(5-chloromethylfluorescein diacetate), respectively, according to the 
manufacturer’s protocol (Invitrogen). Raji B cells (2 × 105) were incu-
bated with 5 µg/ml SEE or vehicle control for 30 min, washed, and 
resuspended in RPMI 1640 medium. For a blocking experiment, Jurkat 
T cells were incubated with TS1/18, TS2/4 (10 µg/ml each), and Cyt D 
(2 µM) for 30 min. For conjugation, equal volumes of B and T cells 
were mixed and incubated at 37°C for indicated time points. The relative 
proportion of orange, green, and orange–green events in each tube was 
determined by two-color flow cytometry using a FACSCanto instrument 
(BD) and analyzed with FlowJo software (Tree Star). The number of gated 
events counted per sample was at least 20,000. The percentage of con-
jugated T cells was determined as the number of dual-labeled (CMFDA 
and CMTMR positive) events divided by the number of CMFDA-positive 
T cells. Mouse CD3+ T cells and SEB-loaded CD19+ B cells conjugates 
were also stained, incubated, and determined as described as described 
in Jurkat T cell–Raji B cell conjugation assay.
In cytotoxic T cell–target cell conjugation assay, CD8+ T cells from 
OTI TCR+/TAGLN2+/+ or OTI TCR+/TAGLN2/ mice were stimulated 
in vitro by OVA 257–264 peptide-loaded DCs in the presence of 10 U/ml 
rIL-2 to generate OVA-specific cytotoxic T cells. 2 d after stimulation, cells 
were washed and seeded into new media daily for 3–6 d. OVA-specific 
cytotoxic T cells were purified by MACS beads, and mixed with EL4 cells, 
which were used as target cells, loaded with 10 µg/ml OVA 257–264 
peptide for 1 h. Conjugates were determined as described in the previ-
ous paragraph.
Purification of recombinant proteins
Expression of recombinant proteins in Escherichia coli BL21 (DE3) cells fol-
lowed the protocol used for transformation of the aforementioned recombi-
nant plasmids. Expression of recombinant proteins was induced by addition of 
0.3 mM IPTG to culture media for 4 h at 37°C, and then, cells were collected. 
25 min at 4°C, and the supernatant was eluted with SDS sample buffer 
(100 mM Tris-HCl, pH 6.8, 4% SDS, and 20% glycerol with bromophenol 
blue) and heated for 5 min. The proteins were separated through 10–12% 
SDS-PAGE gels and were transferred to a nitrocellulose membrane by 
means of Trans-Blot SD semidry transfer cell (Bio-Rad Laboratories). The 
membrane was blocked in 5% skim milk (1 h), rinsed, and incubated with 
intended antibodies in TBS containing 0.1% Tween 20 (TBS-T) and 3% 
skim milk overnight. Excess primary antibody was then removed by washing 
the membrane four times in TBS-T. The membrane was then incubated with 
0.1 µg/ml peroxidase-labeled secondary antibody (anti–rabbit or –mouse) 
for 1.5 h. After three washes with TBS-T, bands were visualized by Western 
Blotting Detection reagents (iNtRON Biotechnology) and were then exposed 
to x-ray film.
For Northern blot analysis, human Northern RNA blot (12 major 
tissues; OriGene) was hybridized with TAGLN2 (5-GCTGAGCGCTAT-
GGCATTAACACCACTGAC-3) and -actin (5-GGGAAATCGTGCGT-
GACATTAAGGAGAAGC-3) cDNAs as probes labeled with -[32P]dCTP 
(PerkinElmer) by random priming using the Prime-It kit (Agilent Technolo-
gies), according to the manufacturer’s protocol. Blots were prehybridized 
for 30–60 min at 68°C in Rapid-hyb buffer (GE Healthcare) and hybrid-
ized for 90 min at 68°C in the presence of cDNA probes, following the 
protocol provided. Blots were washed three times in 2× SSC/0.05% SDS 
at room temperature for 10 min and twice in 0.1× SSC/0.1% SDS at 68°C 
for 5 min then exposed to x-ray film with intensifying screens at 70°C.
RT-PCR and real-time qPCR
Total RNA was isolated from cells or homogenized tissues of C57BL/6 
mice with TRI Reagent (Molecular Research Center, Inc.) and reverse 
transcribed using RT Premix (iNtRON Biotechnology). PCR was per-
formed with the following primers (the respective forward and reverse 
pairs are indicated): human IL2, 5-CACGTCTTGCACTTGTCAC-3 and 
5-CCTTCTTGGGCATGTAAAACT-3; mouse IL2, 5-TGAGCAGGAT-
GGAGAATTACAGG-3 and 5-GTCCAAGTTCATCTTCTAGGCAC-3; 
human GAPDH, 5-CGGAGTCAACGGATTTGGTCGTAT-3 and 5-AGC-
CTTCTCCATGGTGGTGAAGAC-3; mouse GAPDH, 5-GCACAGTCA-
AGGCCGAGAAT-3 and 5-GCCTTCTCCATGGTGGTGAA-3; and 
mouse TAGLN2, 5-GGTGCAGCAGAAGATTGAGAA-3 and 5-GAT-
CTTCTTTACTGGGGCCTG-3. The amplification protocol consisted of 
denaturation at 94°C for 30 s, annealing at 60–62°C for 20 s, and ex-
tension at 72°C for 40 s. The 30 cycles were preceded by denaturation 
at 72°C for 7 min. The expression levels of the human and mouse IL2 
genes were evaluated by real-time RT-PCR, unless otherwise indicated. 
PCR amplification was performed in StepOne Real-Time PCR Systems 
(Applied Biosystems) for continuous fluorescence detection in a total vol-
ume of 10 µl of cDNA/control and gene-specific primers by using SYBR 
Premix Ex Taq (Takara Bio Inc.). The mRNA levels of the target genes, 
relative to GAPDH, were normalized using the following formula: relative 
mRNA expression = 2(Ct of target gene  Ct of GAPDH), where Ct is the threshold 
cycle value. In each sample, the expression of the analyzed gene was 
normalized to that of GAPDH and described as the mRNA level relative 
to GAPDH.
Live imaging
For dynamic T cell imaging, J-GFP and J-TG2_GFP cells were transiently 
transfected with LifeAct (mCherry) by using Amaxa (Lonza) and plated 
on coverslips (18-nm diameter; Marienfeld) coated with human anti-
CD3/28. After preincubation, time-lapse series of randomly selected, 
LifeAct-positive cells in imaging medium (137 mM NaCl, 5 mM KCl, 
1 mM sodium phosphate, 6 mM d-glucose, 1 mM CaCl2, 0.5 mM MgCl2, 
1% BSA, and 10 mM Hepes, pH 7.3) at 37°C were imaged using a 
100×, NA 1.40 oil immersion objective of a laser-scanning confocal 
microscope (FV1000; Olympus). Images from the bottom area of each 
coverslip were recorded every 20 s for a total of 1,000 s. For F-actin 
accumulation at T cell–B cell contact sites, SEE-loaded Raji B cells 
(stained for ICAM-1 with cy5-conjugated CBRIC1/11) were mixed with 
T cells and preincubated in solution for 10 min. After incubation, conju-
gated cells were placed on PLL-coated coverslips and initiated imaging. 
Time-lapse and z-stack images were collected every 10 min, for a total 
of 120 min at 37°C. The data were obtained, processed, and analyzed 
by FLUOVIEW software (Olympus).
Immunofluorescence and confocal microscopy
For immunofluorescence staining, T cells were incubated for 5 min or indicated 
times on PLL or human or mouse anti-CD3/28–coated coverslips. CHO-K1 
cells were incubated for 2 h on 10 µg/ml fibronectin-coated coverslips. 
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Visualization of actin filaments by confocal microscopy
4 µM G-actin was incubated with APB in the presence or absence of 8 µM 
TAGLN2 conjugated with Dylight488 (Thermo Fisher Scientific) for 30 min 
at room temperature. One-tenth of the reaction volume was subsequently 
stained with TRITC-phalloidin and placed on a PLL-coated coverslip. In some 
cases, G-actin was exchanged with 4 µM 488-actin (Hypermol), and mixed 
with TAGLN2 (0–8 µM) and cofilin (0–1 µM) on coverslips coated by 
N-ethylmaleimide–myosin II. The fluorescent images were collected using 
confocal microscopy.
EM analysis
Negative staining was used to visualize F-actin under EM. After actin po-
lymerization, the samples were loaded onto cooper grids coated with For-
mvar and carbon for 30 s and excess liquid was removed with filter paper. 
Actin bound on the grids was stained with 1% uranyl acetate (Sigma- 
Aldrich) for 10 min and then washed with distilled water. Excess liquid was 
removed, and grids were air dried. EM observation was performed using a 
transmission electron microscope (TECNAI G2; FEI) operated at 120 kV.
Determination of cellular F-actin content
Jurkat T cells or mouse T cells were maintained in serum-free medium for 12 h 
and incubated with anti-CD3/28 for the indicated times at 37°C. The reactions 
were terminated by adding 4% paraformaldehyde. Fixed cells were washed 
once with PBS and resuspended in PBS containing 1% BSA and 0.25% Triton 
X-100 for 5 min. After permeabilization, cells were washed, stained for 
30 min with TRITC-phalloidin, and then analyzed by flow cytometry.
Structural modeling of TAGLN2
The crystal structure of human TAGLN1 was used as a template to superim-
pose a TAGLN2 monomer on each of two TAGLN1 molecules using the 
online server SuperPose (Maiti et al., 2004). In addition, the prediction of 
a TAGLN2 homodimer was performed computationally by the ClusPro on-
line server, and the same interface was observed as for the TAGLN1 tem-
plate. Interactions of the TAGLN2 homodimer were analyzed by University 
of California, San Francisco Chimera and Discovery Studio Visualizer soft-
ware (Accelrys Software, Inc.) and optimized by virtual inspection to over-
come the steric hindrances.
Detection of cell surface proteins and intracellular granzyme B  
and perforin
Jurkat T cells, mouse splenocytes, T cells, B cells, and DCs were suspended 
in PBS containing 2% FBS. Cells were stained with fluorescence-conjugated 
antibodies against human CD3-, CD28, LFA-1, ICAM-1, and mouse CD4, 
CD8, CD3-, CD28, B220, CD11c, MHCII, CD86, and CD80 for 30 min 
at 4°C. The corresponding isotype controls were used in each antibodies. 
For intracellular granzyme B and perforin staining, OVA-specific cytotoxic 
T cells were restimulated with 200 nM PMA and 1 µM ionomycin for 4 h 
at 37°C. Brefeldin A was added during the last 2 h of restimulation. Cells 
were stained with anti-CD8, and then fixed, permeabilized, and stained with 
antibodies specific for granzyme B and perforin (eBioscience). Cells were 
acquired on a FACSCanto, and data were analyzed with FlowJo software.
Measurement of secretion of cytokines and granzyme B
Splenic CD3+, CD4+, or CD8+ T cells (5 × 104 cells/sample) were stimu-
lated as described in T cell activation section. After 24–48 h, the amounts 
of IL-2 and IFN- in the supernatants were determined by ELISA with Duo 
Set Mouse ELISA kits (R&D Systems). To measure granzyme B secretion, 
OVA-specific cytotoxic T cells generated previously described in Conjuga-
tion assay section were restimulated with EL4 cells loaded with 10 µg/ml 
OVA 257–264 at a 20:1 (effector cells/target cells) ratio for 4 h. The 
amounts of granzyme B in the supernatants were determined by ELISA.
T cell proliferation assay
CD4+ and CD8+ T cells were labeled for 30 min at 37°C with 10 µM CFSE 
(Molecular Probe) and washed twice in PBS. Labeled T cells were stimu-
lated with anti-CD3/28 antibodies. After 72 h, T cells were collected and 
analyzed by flow cytometry for dilution of CFSE intensity.
In vitro cytotoxic assay
For the in vitro cytotoxic T cell activity assay, OVA-specific T cells were gener-
ated and incubated with target cells described in Measurement of secretion 
of cytokines and granzyme B section at various ratios of effector cells to tar-
get cells. After 4 h, cell-mediated cytotoxicity was determined using CytoTox 
96 NonRadioactive cytotoxicity assay kit (Promega), and the percentage of 
cytotoxicity was calculated according to manufacturer’s instructions.
The cell pellets were resuspended in PBS, sonicated, and centrifuged. 
After centrifugation, recombinant proteins in the supernatant were puri-
fied by affinity chromatography on a His-selected Nickel Affinity Gel 
(Sigma-Aldrich). The gel was equilibrated with 10 volumes of buffer (50 mM 
sodium phosphate, pH 8.0, and 0.3 M NaCl) and incubated with the 
supernatant. The gel was washed with 5 volumes of wash buffer (50 mM 
sodium phosphate, pH 8.0, 0.3 M NaCl, and 10 mM imidazole). The pro-
tein was eluted with increasing concentrations of imidazole up to 250 mM, 
and the collected fractions were dialyzed to remove imidazole. The pro-
teins were assessed by SDS-PAGE and Coomassie blue staining.
In vitro actin cosedimentation assays
Actin cosedimentation assays were performed as described previously 
(Kwon et al., 2013). Nonmuscle actin derived from human platelets was 
purchased (Cytoskeleton, Inc.). Unless otherwise indicated, actin was used 
at a final concentration of 4 µM. Actin was mixed in G buffer (0.2 mM 
CaCl2, 0.2 mM ATP, and 5 mM Tris-HCl, pH 8.0) to produce an actin stock. 
Actin was polymerized in APB (50 mM KCl, 2 mM MgCl2, 0.2 mM ATP, and 
5 mM Tris-HCl, pH 8.0) at room temperature for 1 h and then incubated with 
His-tagged TAGLN2 (8–24 µM) for 30 min at room temperature. 1 µM -ac-
tinin and 1 µM BSA were used as positive and negative controls. Actin fila-
ments with bound proteins were pelleted by centrifugation at 100,000 g for 
2 h (for the F-actin binding assay) or 10,000 g for 10 min (for the F-actin 
bundling assay) at room temperature. Equal amounts of pellet and superna-
tant were resolved using SDS-PAGE, and proteins were visualized by Coo-
massie blue staining. The percentage of actin in supernatant and pellet was 
quantified densitometrically using ImageJ (National Institutes of Health).
Quantification of binding data
Quantitation of actin binding affinity was performed as previously de-
scribed (Kwon et al., 2013). In brief, the intensity ratio of recombinant pro-
tein to F-actin in each pellet was converted to a molar ratio (TAGLN2/actin) 
using standard curves run on each gel that contained known amounts of 
TAGLN2 (0.4–5.6 µM) and actin (4 µM) in molar/molar ratios. Cosedi-
mentation binding data were plotted as a function of the free TAGLN2 
concentration added and fitted according to the equation: [Cbound]/[actin] 
= Bmax[Cfree]/Kd + [Cfree], where [Cbound] and [Cfree] are the bound and free 
concentrations of TAGLN2, [actin] is the total actin concentration, Bmax is 
the maximal molar binding ratio, and Kd is the dissociation constant (micro-
molars). Data were fit using the Excel Solver package (Microsoft) by vary-
ing the values of Bmax and Kd and minimizing the sum of squares between 
the actual and predicted binding ratios.
Actin polymerization assay
Actin polymerization assays were performed using the Actin Polymeriza-
tion Biochem kit (Cytoskeleton, Inc.) in which the rate of conversion of 
pyrene-labeled G-actin into F-actin was monitored. In brief, pyrene-labeled 
G-actin was thawed at 4°C and centrifuged at 14,000 g for 30 min at 4°C 
to remove residual F-actin. Unless otherwise indicated, 4 µM G-actin, 
10 nM bovine brain Arp2/3 complex (Cytoskeleton, Inc.), recombinant 
human GST-tagged VCA domain of WASp (400 nM; Cytoskeleton, Inc.), 
and His-tagged TAGLN2 (4 µM) were used for polymerization assay. Actin 
polymerization was initiated by adding G-actin stock to the wells with APB 
and target proteins. The plate was read with a fluorometer (GEMINI XS; 
Molecular Probe), with excitation at 355 nm and emission at 405 nm. 
Fluorescence data were zeroed by subtracting baseline fluorescence from 
all fluorescence values and normalized by dividing all fluorescence values 
by the mean fluorescence of at the plateau.
Actin depolymerization assay
For monitoring actin filament disassembly, 20 µM pyrene G-actin was 
polymerized in APB for 1 h in the presence or absence of various concen-
trations of TAGLN2 or phalloidin (20 µM; Cytoskeleton, Inc.). Reactants 
were then diluted to 4 µM with G-actin buffer to induce spontaneous 
depolymerization. In the case of cofilin-mediated depolymerization, 1 µM 
cofilin (Cytoskeleton, Inc.) in G-buffer was added to F-actin reactants 
during the dilution step. Decreasing pyrene fluorescence was measured 
as in the actin polymerization assay. Normalization for fluorescence in-
tensity was performed by dividing fluorescence value of reactants with 
fluorescence value of the reactant in the presence of phalloidin at each 
time point. Changes in fluorescence intensity (F) during depolymeriza-
tion were calculated by subtracting the fluorescence measured at last 
time point from the fluorescence measured at initial time point. Changes 
of each sample (F of TAGLN2 or TAGLN2 + cofilin) were subsequently 
divided by F of cofilin.
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Retroviral transduction in mouse T cells
Before retroviral transduction, mouse CD3+ T cells from TAGLN2+/+ and 
TAGLN2/ mice were incubated in 10 µg/ml anti-CD3–coated coverslips 
with 2 µg/ml anti-CD28 and 10 µg/ml rIL-2 for 48 h. A total of 6 × 106 
retroviral packaging cells (platinum-E cells; Cell Biolabs) were plated 
overnight in 10-cm2 dishes. Retroviral particles were generated by trans-
fection with retroviral vectors (empty vector, TG2, and TG2ABM) and 
pCL-Eco packaging vector using Lipofectamine 2000 (Invitrogen). After 
48 h, virus supernatants (1 ml) were harvested, mixed with 106 mouse 
T cells and polybrene (8 µg/ml) in a 12-well plate and centrifuged for 90 min 
at 2,000 g at 32°C with 20 U/ml rIL-2. The transduced T cells were main-
tained with fresh media with rIL-2 and expanded for 5–8 d.
Statistics
Mean values were calculated using data taken from at least three indepen-
dent experiments conducted on different days. Where significance testing 
was performed, unpaired Student’s t tests and one-way analysis of vari-
ance tests were used. Differences between groups were considered signifi-
cant at P < 0.05.
Online supplemental material
Fig. S1 shows that TAGLN2 is expressed in immunogenic tissues and cells 
and knockdown of TAGLN2 reduces T cell activation. Fig. S2, which cor-
responds to Fig. 1 F, shows individual z-stack images acquired as opti-
cal sections from bottom to top. Fig. S3 shows the strategy to generate 
TAGLN2 knockout mice and characterization of their population, develop-
ment, and expression of indicated surface molecules. Fig. S4 shows the 
strategy to generate GFP-T or TG2_GFP-T transgenic mice and charac-
terization of their T cell development and cytokine secretion in response 
to TCR activation. Fig. S5 shows the cellular concentrations of TAGLN2, 
cofilin, and actin, as determined by quantitative Western blotting. Video 1, 
corresponding to Fig. 1 E, shows a 3D view of TAGLN2_GFP and ICAM-1 
localization at the contact site of Jurkat T cells and Raji B cells. Videos 2–4, 
corresponding to Fig. 1 F, show localization of TAGLN2, Arp3, myosin IIA, 
and F-actin in Jurkat T cells placed on anti-CD3/28–coated coverslips. 
Videos 5 and 6, corresponding to Fig. 2 A, show real-time F-actin ring 
formation and dynamic localization of TAGLN2 and actin during J-GFP 
or J-TG2_GFP cell spreading on anti-CD3/28–coated coverslips. Videos 7 
and 8, corresponding to Fig. 8 B, show colocalization of cofilin, TAGLN2, 
and F-actin in Jurkat T cells placed on anti-CD3/28–coated coverslips. 
Online supplemental material is available at http://www.jcb.org/cgi/ 
content/full/jcb.201407130/DC1.
Image acquisition was performed using the imaging facility of the Bio-Imaging 
Research Center at the Gwangju Institute of Science and Technology (GIST).
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